Previous page Next page Main page E-Mail
Navigation
IACMAC
Ministry of Health of Russian Federation
Russian Academy of Medical Sciences
Interregional Association for Clinical Microbiology
and Antimicrobial Chemotherapy

(IACMAC)


PROGRAMME
PROGRAMME

OF THE IV INTERNATIONAL
OF THE IV INTERNATIONAL

IACMAC CONFERENCE
IACMAC CONFERENCE

"ANTIMICROBIAL THERAPY"
"ANTIMICROBIAL THERAPY"


20-21 June 2001
Moscow, Russian Federation
Conference Venue: Russian Academy of State Service (RASS)
of the President of the Russian Federation


WITH PARTICIPATION OF

American Society for Microbiology (ASM)
European Commission (EC)
European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Federation of European Societies for Chemotherapy and for Infection (FESCI)
International Society for Infectious Diseases (ISID)
Paul-Erlich Gesellschaft (PEG)




Tuesday, 19 June 2001

Round-table discussion
RESPIRATORY FLUOROQUINOLONES
Supported by "Aventis Pharma"
19.00 - 19.20
Evolution of fluoroquinolones as drugs for treatment of respiratory tract infections A. Bryskier (France)
19.20 - 19.40 Fluoroquinolones activity against Gram-positive cocci: results of multicenter study in Russia L. Stratchounski (Russia)
19.40 - 20.00 Management of pneumonia: advantages of monotherapy A. Chuchalin (Russia)
20.00 - 20.20 The role of fluoroquinolones in the modern therapy regimens A. Sinopalnikov (Russia)
20.20 - 20.30 General discussion

Wednesday, 20 June 2001

9.00 - 9.15
Opening ceremony V. Pokrovsky (Russia),
S. Tkachenko (Russia),
J. Acar (France),
S. Lerner (USA)
PLENARY SESSION. Main Hall
Co-chairmen: A. Egorov (Russia), C.E. Nord (Sweden), V. Pokrovsky (Russia)
9.15 - 9.40 History of antibioticotherapy in Russia: lessons for the New Millennium Yu. Dudnik (Russia)
  9.40 - 10.05 Current state of antimicrobial resistance in Europe H. Goossens (Belgium)
10.05 - 10.25 Antimicrobial resistance in Russia L. Stratchounski (Russia)
10.25 - 10.35 Coffee break
10.35 - 11.00 Modern achievements in antibacterial therapy: where are we now? A. Bryskier (France)
11.00 - 11.25 Strategy of the virulence of microorganisms S. Sidorenko (Russia)
11.25 - 11.50 Clinical significance of the microecology disturbances during antibacterial therapy C.E. Nord (Sweden)
11.50 - 12.15 Coffee break
SYMPOSIA SESSION
Symposium I. Hall 3
Modern tendencies in the therapy of mycoses
Co-chairmen: S. Burova (Russia), N. Klimko (Russia), M. Richardson (UK)
Supported by "Gilead" and "Pfizer"
12.15 - 12.45
Modern antifungals for the therapy of invasive mycoses M. Richardson (UK)
12.45 - 13.05 Candidemia and acute disseminated candidosis in ICU patients N. Klimko (Russia)
13.05 - 13.25 Diagnosis and treatment of invasive aspergillosis A. Maschan (Russia)
13.25 - 14.00 Current approaches to the management of fungal urinary tract infections K. Naber (Germany)
14.00 - 15.00 Lunch
Symposium II. Main Hall
Policy of the selection of antibacterial agents in ICUs
Co-chairmen: B. Gelfand (Russia), L. Stratchounski (Russia), S. Yakovlev (Russia)
Supported by "Merck, Sharp & Dohme"
12.15 - 12.35 Pharmacological and microbiological basis for usage of carbapenems S. Yakovlev (Russia)
12.35 - 13.05 De-escalation therapy of serious infections └. Rodloff (Germany)
13.05 - 13.25 Role of carbapenems in the therapy of infections caused by ESBL-producing microorganisms L. Stratchounski (Russia)
13.25 - 13.45 Algorithms of the management of patients with surgical sepsis Russia B. Gelfand (Russia)
13.45 - 14.00 General discussion
14.00 - 15.00 Lunch
Symposium III. Main Hall
New possibilities of therapy of serious bacterial infections
Co-chairmen: A. Rodloff (Germany), S. Sidorenko (Russia), L. Stratchounski (Russia)
Supported by "Pfizer"
15.00 - 15.30 In vitro activity of sulperazone and its implications for clinical practice └. Rodloff (Germany)
15.30 - 16.00 Modern tendencies in the empiric therapy of patients with intra-abdominal infections L. Stratchounski (Russia)
16.00 - 16.30 Position of b-lactam/b-lactamase inhibitor combinations in lung infections H. Lode (Germany)
16.30 - 17.00 Optimization of selection of antibacterial drugs in immunocompromised patients G. Klyasova (Russia)
17.00 - 17.30 Clinical experience with b-lactam/b-lactamase inhibitors V. Korten (Turkey)
Symposium IV. Hall 3
Surveillance of diphtheria in Europe and Russian Federation
Co-chairmen: A. Efstratiou (UK), P. Grimont (France), N. Maksimova (Russia)
Within the remit of the European Commission DG RTD INCO Copernicus programme IC15.CT.98.0302
15.00 - 15.30 Current situation with diphtheria in Europe: role of EC programmes in microbiological surveillance of diphtheria A. Efstratiou (UK)
15.30 - 16.00 Laboratory diagnosis of diphtheria I. Mazurova (Russia)
16.00 - 16.30 Molecular typing of Corynebacterium spp. The C.diphtheriae ribotype project P. Grimont (France)
16.30 - 17.00 Control and management of diphtheria: WHO view N. Emiroglu (Denmark)
17.00 - 17.30 General discussion

Thursday, 21 June 2001

PLENARY SESSION. Main Hall
Co-chairmen: H. Giamarellou (Greece), Yu. Lobzin (Russia), A. Firsov (Russia)
9.00 - 9.25
Bioterrorism: role of antimicrobial agents E. Rubinstein (Israel)
9.25 - 9.50 Clinical significance of antibiotic influence of antibiotics on immunity M.-T. Labro (France)
  9.50 - 10.15 Problems of antibiotic prophylaxis in surgery L. Zueva (Russia)
10.15 - 10.30 Coffee break
10.30 - 11.00 Antibiotic policy in hospital settings H. Giamarellou (Greece)
11.00 - 11.30 Epidemiology of resistance in Streptococcus pneumoniae P. Appelbaum (USA)
11.30 - 12.00 Reasons for non-efficacy of antibiotics J. Acar (France)
12.00 - 12.05 Result of ­The Best poster˝ competition
SYMPOSIA
Symposium V. Hall 3
Perspectives of anti-infective therapy in the new millennium
Co-chairmen: Yu. Belousov (Russia), B. Gelfand (Russia), P. Dellinger (USA)
Supported by "GlaxoSmithKline"
10.00 - 10.20
Principles of development of antibiotic formulary for multi-purpose hospitals based on pharmacoeconomic approach Yu. Belousov (Russia)
10.20 - 10.40 Rational antibacterial therapy of nosocomial pneumonia A. Sinopalnikov (Russia)
10.40 - 11.20 Antibiotic prophylaxis for scheduled surgical procedures P. Dellinger (USA)
11.20 - 11.40 Algorithms of antimicrobial therapy in critical neutropenia G. Klyasova (Russia)
11.40 - 12.00 Place of mupirocin in eradication of staphylococcal carriage N. Dmitrieva (Russia)
Symposium VI. Main Hall
Federal guidelines for physicians as a tool for optimization of antimicrobial therapy
Co-chairmen: Yu. Belousov (Russia), H. Lode (Germany), └. Tzoi (Russia)
Under auspices of All-Russian Public Foundation "Human Health" and PEG
12.15 - 12.40 From clinical guidelines and standards to Federal guidelines for phisicians for usage of pharmaceutical agents Yu. Belousov (Russia)
12.40 - 13.05 Practice of usage of drug formulary in pneumonia H. Lode (Germany)
13.05 - 13.35 Peculiarities and stages of development of regional formulary of antimicrobials A. Shalunov (Russia)
13.35 - 14.00 Rational choice of antibiotics for the therapy of gram-positive infections S. Yakovlev (Russia)
14.00 - 15.00 Lunch
Symposium VII. Molecular epidemiology and diagnostics of bacterial infections
Co-chairmen: M. Achtman (Germany), E. Kaczmarski (UK), A. Platonov (Russia)
12.15 - 12.40 Molecular epidemiology of bacterial infections M. Achtman (Germany)
12.40 - 13.00 Genetic methods for detection of antibacterial resistance M. Edelstein (Russia)
13.00 - 13.30 Non-cultural methods of diagnosis of meningococcal infections E. Kaczmarski (UK)
13.30 - 14.00 Genodiagnostics and genotyping of pathogens causing bacterial meningitis in Russia A. Platonov (Russia)
14.00 - 14.30 Lunch
Symposium VIII. Main Hall
Position of parenteral cephalosporins in the therapy of nosocomial infections
Co-chairmen: J. Acar (France), V. Rudnov (Russia), S. Sidorenko (Russia)
Supported by "Brisol-Mayers Squibb"
15.00 - 15.30 New trends in etiology of infections in ICUs J. Acar (France)
15.30 - 16.00 Usage of cephalosporins for the therapy of pseudomonal infections S. Sidorenko (Russia)
16.00 - 16.30 Pharmacoeconomic approaches to the selection of cephalosporins V. Rudnov (Russia)
16.30 - 17.00 Current views on the therapy of nosocomial pneumonia R. Kozlov (Russia)
17.00 - 17.30 General discussion
Symposium IX. Hall 3
Perspectives of usage of new fluoroquinolones
Co-chairmen: E. Rubinstein (Israel), L. Stratchounski (Russia), V. Yakovlev (Russia)
15.00 - 15.30 Modern problems of antibacterial therapy of respiratory infections E. Rubinstein (Israel)
15.30 - 16.00 Antimicrobial resistance in Russia and respiratory fluoroquinolones L. Stratchounski (Russia)
16.00 - 16.30 Place of fluoroquinolones in therapy of acute exacerbations of chronic bronchitis └. Synopalnikov (Russia)
16.30 - 17.00 Strategy of choice of antibiotics in ambulatory practice. Possibilities of usage of respiratory fluoroquinolones S. Yakovlev (Russia)
17.00 - 17.30 General discussion

© 2000-2006 IAC SSMA · E-mail: website@antibiotic.ru